– Findings show key mutations and evolution of U.K. SARS-CoV-2 compared to earlier lineages account for upregulation of innate immune antagonists, which hamper immune response and allow for increased viral replication and duration of infection – SAN FRANCISCO, Calif. and
Seattle, June 07, 2021 (GLOBE NEWSWIRE) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced its partnership with BioNTech SE (Nasdaq BNTX) to further supply Plasmid DNA (pDNA) starting material for the Pfizer-BioNTech COVID-19
– Findings show key mutations and evolution of U.K. SARS-CoV-2 compared to earlier lineages account for upregulation of innate immune antagonists, which hamper immune response and allow for increased viral replication and duration of infection – SAN FRANCISCO, Calif. and
SEOUL, South Korea, June 07, 2021 (GLOBE NEWSWIRE) — Stellantis N.V. has announced that Nexen Tire, a leading global tire manufacturer, has received the “Best Supplier Award” in the Competitiveness Category of its first annual supplier awards. The awards ceremony
TORONTO, June 07, 2021 (GLOBE NEWSWIRE) — Sophi.io, The Globe and Mail’s artificial intelligence-powered optimization and prediction platform, was announced as a winner of the International News Media Association (INMA) Global Media Awards in two categories, Best Use of Data
June 7, 2021 Intelligent, scalable, secure and interoperable solutions seamlessly connect people, technology and data to support clinical decisions at every point of care to help improve health outcomes, patient and staff experience and reduce cost of care Philips shares
June 7, 2021 Healthcare leaders partner to streamline the path from cancer diagnosis to survivorship for better outcomes Amsterdam, the Netherlands, and Stockholm, Sweden – Royal Philips (NYSE: PHG, AEX: PHIA), and Elekta (EKTA-B.ST) today signed agreements to deepen their
REGULATED INFORMATION INSIDE INFORMATION Nyxoah BETTER SLEEP Trial Reaches its Primary Endpoints Mont-Saint-Guibert, Belgium – 7 June 2021, 7:00 am CET / 1:00 am ET – Nyxoah SA (Euronext Brussels: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on